Ben-Noon Alon
SEC insider (Form 3/4/5 filer). CIK 0001901198. Chief Executive Officer at NeuroSense Therapeutics Ltd. (NRSN). 1 reported Form 4/5 transaction since Sep 2024; latest on Jun 16, 2026. Located in HERZLIYA.
Companies Ben-Noon Alon has filed insider reports for
- NeuroSense Therapeutics Ltd. (NRSN): Officer, Chief Executive Officer
Ben-Noon Alon
CIK: 0001901198
Transaction Breakdown
Open Market Buys (P)1 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NRSN
NeuroSense Therapeutics Ltd.
Officer